- Additional Proxy Soliciting Materials (definitive) (DEFA14A)
June 25 2009 - 3:20PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
_______________
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of
1934
Date of Report (Date of earliest event
reported):
June 25, 2009
AVIGEN, INC.
(Exact name of registrant as specified in charter)
|
Delaware
|
000-28272
|
13-3647113
|
|
(State or
other jurisdiction of
|
(Commission
File Number)
|
(I.R.S.
Employer Identification
|
|
incorporation)
|
|
No.)
|
1301 Harbor Bay Parkway
Alameda,
California 94502
(Address of principal
executive offices and zip code)
Registrant’s telephone number, including
area code:
(510) 748-7150
_____________________________
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425)
x
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a -12)
o
Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
o
Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Item 8.01. Other Events.
On June 25, 2009, Avigen, Inc. and
MediciNova, Inc. announced that they were in negotiations regarding a possible
acquisition of Avigen by MediciNova, and confirmed key terms of their
understanding. The press release is attached hereto as Exhibit 99.1 and
incorporated by reference here.
Item 9.01. Financial Statements and
Exhibits.
(d) Exhibits
|
Exhibit No.
|
Description
|
|
99.1
|
Press Release, dated June 25, 2009, announcing MediciNova, Inc. and
Avigen, Inc. Confirm Understanding for Key Terms for a Business
Combination
|
|
|
|
SIGNATURE
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: June 25,
2009
|
|
AVIGEN,
INC.
|
|
|
|
|
By:
|
/s/ Kirk Johnson
|
|
|
|
Kirk Johnson,
Ph.D
|
|
|
|
Vice President
Research & Development
|
INDEX TO EXHIBITS
|
Exhibit
No.
|
Description
|
|
99.1
|
Press Release, dated June 25, 2009, announcing MediciNova, Inc. and
Avigen, Inc. Confirm Understanding for Key Terms for a Business
Combination
|
|
|
|
Avigen (MM) (NASDAQ:AVGN)
Historical Stock Chart
From May 2024 to Jun 2024
Avigen (MM) (NASDAQ:AVGN)
Historical Stock Chart
From Jun 2023 to Jun 2024
